Hims & Hers Health, Inc. (HIMS) ended the recent trading session at $25.90, demonstrating a +1.93% swing from the preceding day's closing price. This move outpaced the S&P 500's daily gain of 0.16%.
Fintel on MSN4d
Citigroup Downgrades Hims & Hers Health (HIMS)Fintel reports that on January 10, 2025, Citigroup downgraded their outlook for Hims & Hers Health (NYSE:HIMS) from Neutral ...
Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health ...
The Zacks Medical Info Systems industry, to which Hims & Hers Health belongs, has lost 7.7% over this period. Now the key question is: Where could the stock be headed in the near term? While media ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback